Medicines Play an Important Role in Controlling Health Care Costs

07.08.13 | By

Research shows that properly adhering to medications is a major challenge, but patients who take their medications as prescribed are more likely to have better outcomes.

New Insights into Part D Specialty Tier

07.03.13 | By

According to new research by Milliman, a leading actuarial consulting firm, only about 3.3 percent of Part D enrollees filled a prescription for at least one specialty drug in 2011, a very small portion of total Part D enrollment. 

Controlling Non-Communicable Diseases With Our Phones

07.02.13 | By

In the future, we just might be able to control non-communicable diseases with our phones.

An Encounter with Heart Disease

07.02.13 | By

We all know someone impacted by heart disease or stroke. Well that applies to the researchers working on medicines to combat these deadly diseases, as well. Not surprising when you consider that heart disease is the leading cause of death for both men and women, with someone dying from a heart disease related event every minute.

Exploring Health Policy

07.02.13 | By

As we continue to explore health policy through our ‘Conversations’ forum, today we’re introducing the next question and encourage you to weigh in with your thoughts:

“Every day, thousands of Americans turn 65. How do we help ensure that the U.S. system is ready to meet their needs?

PhRMA & BIO Establish Industry PDUFA Tracking Database

07.02.13 | By

As a recent update on implementation of the Prescription Drug User Fee Act (PDUFA) explained, a new review program for new molecular entity (NME) new drug applications (NDA) and original biologic license applications (BLA) was established under

‘Conversations’ Round-Up

07.01.13 | By

Last week, we introduced ‘Conversations,’ a new forum that provides experts, innovators, patients and other stakeholders an opportunity to share ideas through a live, ongoing dialogue about the future of health care.

Getting to the Heart of the Matter

07.01.13 | By

We often discuss in the Catalyst the challenges and promise inherent in the drug discovery process and its impact on patients. And at times talk about how medicines, when used appropriately, can be a valuable part of the solution to controlling health care costs in the U.S.

Week In Review: Engaging in Conversation on Key Issues

06.28.13 | By

This week, we launched our “Conversations” forum as part of our larger goal of engaging a broad spectrum of thinkers, patient advocates, providers and manufacturers on their thoughts about pressing health care questions. As Matt Bennett, our SVP of Communications, said, “No one organization has all the answers, so it’s important to bring together diverse contributors to weigh in.”

Illegal Pharmacies Shut Down

06.28.13 | By

More than 9,600 websites that illegally sell potentially dangerous, counterfeit drugs to patients were targeted this week by a partnership that included INTERPOL, the FDA, international regulatory and law enforcement bodies, as well as pharmaceutical companies. The partnership announced yesterday that 1,677 of the websites were seized and shut down.


Subscribe to RSS - Opinion